BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23555858)

  • 1. Immune cells from SR/CR mice induce the regression of established tumors in BALB/c and C57BL/6 mice.
    Koch J; Hau J; Pravsgaard Christensen J; Elvang Jensen H; Bagge Hansen M; Rieneck K
    PLoS One; 2013; 8(3):e59995. PubMed ID: 23555858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.
    Riedlinger G; Adams J; Stehle JR; Blanks MJ; Sanders AM; Hicks AM; Willingham MC; Cui Z
    BMC Cancer; 2010 May; 10():179. PubMed ID: 20438640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular cancer resistance of the SR/CR mouse.
    Koch J; Hau J; Jensen HE; Nielsen CH; Rieneck K
    APMIS; 2012 Dec; 120(12):974-87. PubMed ID: 23030360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
    Mayrand SM; Healy PA; Torbett BE; Green WR
    Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of the cancer-resistant phenotype in SR/CR mice and the effect of litter seriation.
    Koch J; Boschian A; Hau J; Rieneck K
    In Vivo; 2008; 22(5):565-9. PubMed ID: 18853747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.
    Sanders AM; Stehle JR; Blanks MJ; Riedlinger G; Kim-Shapiro JW; Monjazeb AM; Adams JM; Willingham MC; Cui Z
    BMC Cancer; 2010 Mar; 10():121. PubMed ID: 20356394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1.
    Handisurya A; Day PM; Thompson CD; Bonelli M; Lowy DR; Schiller JT
    PLoS Pathog; 2014 Aug; 10(8):e1004314. PubMed ID: 25121947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.
    DiLillo DJ; Yanaba K; Tedder TF
    J Immunol; 2010 Apr; 184(7):4006-16. PubMed ID: 20194720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice.
    Stehle JR; Blanks MJ; Riedlinger G; Kim-Shapiro JW; Sanders AM; Adams JM; Willingham MC; Cui Z
    BMC Cancer; 2009 Sep; 9():328. PubMed ID: 19754973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of T-cell subsets in acute and persistent E-55+ murine leukemia virus infection in susceptible progressor and resistant long-term nonprogressor mouse strains. Women and Infants Transmission Study.
    Avidan N; Sieck TG; Blank KJ
    Clin Immunol Immunopathol; 1997 Dec; 85(3):282-8. PubMed ID: 9400628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease in BALB/cAnNCr mice is related to absence of a CD4+ T-cell subset.
    Karls KA; Denton PW; Melvold RW
    Mult Scler; 2002 Dec; 8(6):469-74. PubMed ID: 12474985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles.
    Andreasson K; Eriksson M; Tegerstedt K; Ramqvist T; Dalianis T
    PLoS One; 2010 Jul; 5(7):e11580. PubMed ID: 20657846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
    Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of intraepithelial lymphocytes, lamina propria leukocytes, and isolated lymphoid follicles in the large intestine of mice infected with the intestinal nematode parasite Trichuris muris.
    Little MC; Bell LV; Cliffe LJ; Else KJ
    J Immunol; 2005 Nov; 175(10):6713-22. PubMed ID: 16272327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors.
    Yorty JL; Tevethia SS; Schell TD
    Cancer Immunol Immunother; 2008 Jun; 57(6):883-95. PubMed ID: 18004562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
    Bruchard M; Geindreau M; Perrichet A; Truntzer C; Ballot E; Boidot R; Racoeur C; Barsac E; Chalmin F; Hibos C; Baranek T; Paget C; Ryffel B; Rébé C; Paul C; Végran F; Ghiringhelli F
    Nat Immunol; 2022 Feb; 23(2):262-274. PubMed ID: 35102345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
    Saitoh O; Nagayama Y
    Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.